National Media Spotlight: Dr. Omics Labs Showcases Clinical DNA Tests at the International Trade Show, Greater NOIDA

⭐ Featured Achievement

Dr. Omics Labs garnered prime national media coverage while showcasing its population-specific DNA testing kits at the prestigious International Trade Show, NOIDA

About this Achievement

Dr. Omics Labs was featured prominently across premier national media networks, including NDTV and Zee Media, highlighting the company’s breakthrough innovations in personalized healthcare and population-targeted genomics at the recent International Trade Show in Greater NOIDA. The exhibition, hosted in alignment with the GIMS Centre for Medical Innovation, provided a global platform to spotlight Dr. Omics Labs’ clinical-grade DNA sample collection kits and diagnostic assays designed specifically for the Indian genetic landscape.

Pioneering Population-Specific Genomics for India

Most global genomic reference datasets and therapeutic recommendations are derived from Western cohorts, creating a critical clinical gap when applied to Indian demographics. Dr. Omics Labs addresses this disparity by engineering DNA diagnostic workflows and pharmacogenomic panels calibrated directly to Indian genetic architecture. During the media interactions at the Greater NOIDA trade show, our leadership elaborated on how population-specific sequencing translates directly to higher diagnostic sensitivity, accurate drug response prediction, and better therapeutic outcomes.

Featured Diagnostic Solutions & Clinical Tests

The national coverage spotlighted Dr. Omics Labs’ comprehensive range of specialized preventive and clinical genetic assays showcased at the event:

Pharmacogenomic (PGx) Testing: Precision drug-gene response assays spanning Cardiology, Oncology, Diabetology, and Neurology to eliminate adverse drug reactions (ADRs) and identify optimal dosing regimens.
Complex Disease Predisposition Panels: Advanced risk screening for early-onset type-2 diabetes, cardiovascular diseases, and hereditary oncological markers.
Nutrigenomics & Wellness Profiles: Deep genetic profiling covering metabolic rates, micronutrient absorption, and exercise physiology to inform targeted preventative regimens.
Non-Invasive DNA Sample Collection Kits: Certified, user-friendly saliva collection systems engineered for high-integrity molecular preservation and seamless transport to accredited sequencing facilities.

Institutional Trust & Validation

Dr. Omics Labs operates at the intersection of translational bioinformatics and clinical genomics, supported by a robust ecosystem of government, academic, and technological institutions:

Incubation & Clinical Alignment: Accelerated through the Government Institute of Medical Sciences (GIMS) Centre for Medical Innovation, which partnered with us at the International Trade Show.
High-Throughput Sequencing Infrastructure: Backed by advanced Next-Generation Sequencing (NGS) workflows and cloud bioinformatics pipelines validated with global technology partners, including Illumina, Pfizer, and Amazon Web Services (AWS).
Research-Backed Standards: Every genetic screening pipeline adheres strictly to global quality control standards, ensuring clinicians, researchers, and patients receive actionable, reproducible clinical intelligence.

Transforming Preventive Healthcare in India